CELLINK launches biotech-focused podcast
Extends area of interest beyond bioprinting

CELLINK, the first bioink company in the world, announced the launch of their new podcast – Biotech Buzz. Here you can get the latest scoop on the world of biotech. CELLINK’s Chief Communications Officer, Ariel Kramer, is the host of Biotech Buzz and will be interviewing industry leaders from around the globe. Biotech Buzz kicked off their podcast with an interview with Jan-Olof Jacke, Sweden’s CEO of pharmaceutical giant AstraZeneca.
You can listen to the first episode on soundcloud: https://soundcloud.com/cellink
“We are really excited about the launch of Biotech Buzz. This industry is constantly moving at a rapid pace and we want to be apart of keeping the world informed” Kramer said.
Biotech Buzz will feature researchers, top industry executives and entrepreneurs to name a few, to give their listeners a wide range of interesting content.
If you’re short on free time, no fear. Biotech Buzz episodes are kept within the 10-20 minute range for a quick on the go-experience. “We want our listeners to be able to tune in without having to worry about cutting out too much time. Occasionally we will do some longer episodes, but let’s face it, we are living in a fast paced world.” said Kramer.
Erik Gatenholm, CEO of CELLINK not only envisions CELLINK to be a leader in the world of 3D Bioprinting, but a leader in the world of biotech. “At CELLINK we believe it’s extremely important to stay up to date and connected within the biotech industry. We love to see what’s happening around the world and what new technologies and discoveries are being made. We want to strengthen the community and we hope that Biotech Buzz will educate and inspire our listeners.”
CELLINK will be broadcasting live at the American Society for Cell Biologists (ASCB) meeting in San Francisco and at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) conference in San Diego this December.